ГоловнаArchive of numbers2023Volume 31, issue 1 (114)Features of primary psychopathological disorders due to Coronavirus disease Covid-19
Title of the article Features of primary psychopathological disorders due to Coronavirus disease Covid-19
Authors Maruta Natalia
Fedchenko Viktoriya
Panko Tamara
Yavdak Iryna
Semikina Olena
Lapinska Oksana
In the section DIAGNOSTICS AND THERAPY OF NEUROLOGICAL, MENTAL AND NARCOLOGICAL DISORDERS
Year 2023 Issue Volume 31, issue 1 (114) Pages 60-69
Type of article Scientific article Index UDK 616.9-036.4-07-08:616.89-06 Index BBK -
Abstract DOI: https://doi.org/10.36927/2079-0325-V31-is1-2023-9

 The purpose of the study was to study the features of primary mental disorders that arose as a result of coronavirus disease. In order to realize the goal of the study in the borderline psychiatry of the "INPN of NAMS of Ukraine" SI, 97 patients were examined for the first time psychic disorders suffered from Covid-19 and were exposed to the Sars-CV-2 pandemic stressors. The diagnosis was made taking into account the criteria of ICD-10 (F32.0 — F32.2 — 34 patients, F40 — F45—32 patients, F06.3 — F06.6 — 31 patients). It is established that the surveyed patients with neurotic, stress, and somatoform disorders indicators of objective and subjective assessment of the severity of anxiety indicate the importance for patients with this group of personal assessment of what is happening to them. The indicators of depression in these patients corresponded to “light” and “moderate level” — the average score in the group was 20.16 points. The overall level of depression in patients with depressive episodes (F32.0 — F32.2) and in patients with mental disorders of organic genesis (F06.3 — F06.6), on avera- ge, in groups corresponded to “moderate” depression level — average points on the MADRS scale. and 23.04 points respectively. For patients with Covid-19, anxiety disorders of varying intensity are characteristic. The highest alarm rates were observed in the group of neurotic patients, related to stress and somatoform disorders, which on average in the group correspond to a moderate level ((27.92 ± 3.42) points). The intensity of anxiety in patients with depressive episodes and mental disorders of organic genesis was in the range from mild to moderate ((23.09 ± 2.86) points and (24.58 ± 3.19) points, respectively). In the structure of anxiety disorders in patients with neu- rotic, stress, and somatoform disorders, somatic and vege tative symptoms prevail, significant differences are established between groups of patients with neurotic, stress, and somatoform disorders and patients with depressive episodes. ((1.56 ± 0.31) points and (0.39 ± 0.22) respectively, p ≤ 0.05), vegetative symptoms ((2.24 ± 0.34) points and (1,12 ± 0.27), respectively, p ≤ 0.01).
Key words primary psychopathological manifestations, consequences of COVID-19
Access to full text version of the article pdf download
Bibliography 1. Talevi D, Socci V, Carai M, Carnaghi G, Faleri S, Trebbi E, di Bernardo A, Capelli F, Pacitti F. Mental health outcomes of the CoViD-19 pandemic. Riv Psichiatr. 2020 May-Jun;55(3):137-144. doi: 10.1708/3382.33569.
2. Leo Sher, The impact of the COVID-19 pandemic on suicide rates, QJM: An International Journal of Medicine, Volume 113, Issue 10, October 2020, Pages 707–712, https://doi.org/10.1093/ qjmed/hcaa202.
3. WHO Coronavirus (COVID-19), Dashboard, 2023. https:// covid19.who.int/.
4. United Nations. Policy Brief: COVID-19 and the Need for Action on Mental Health. May 2020. URI: https://unsdg.un.org/ sites/default/files/2020-05/UN-Policy-Brief-COVID-19-and- mental-health.pdf (Accessed on July 05, 2020).
5. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the cur- rent evidence. Brain Behav Immun. 2020 Oct;89:531-542. doi: 10.1016/j.bbi.2020.05.048.
6. Anestis MD, Bond AE, Daruwala SE, Bandel SL, Bryan CJ. Suicidal Ideation Among Individuals Who Have Purchased Firearms During COVID-19. Am J Prev Med. 2021 Mar;60(3):311- 317. doi: 10.1016/j.amepre.2020.10.013.
7. Aquila I, Sacco MA, Ricci C, Gratteri S, Montebianco Abenavoli L, Oliva A, Ricci P. The role of the COVID-19 pandemic as a risk factor for suicide: What is its impact on the public mental health state today? Psychol Trauma. 2020 Aug;12(S1):S120-S122. doi: 10.1037/tra0000616.
8. Barberis N, Cannavò M, Cuzzocrea F, Verrastro V. Suicidal Behaviours During Covid-19 Pandemic: A Review. Clin Neuropsychiatry. 2022 Apr;19(2):84-96. doi: 10.36131/ cnfioritieditore20220202.
9. Xiang YT, Jin Y, Cheung T. Joint International Collaboration to Combat Mental Health Challenges During the Coronavirus Disease 2019 Pandemic. JAMA Psychiatry. 2020 Oct 1;77(10):989- 990. doi: 10.1001/jamapsychiatry.2020.1057.
10. Galea S, Merchant RM, Lurie N. The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention. JAMA Intern Med. 2020;180(6):817–818. doi: 10.1001/jamainternmed.2020.1562
11. Reger MA, Stanley IH, Joiner TE. Suicide Mortality and Coronavirus Disease 2019-A Perfect Storm? JAMA Psychiatry. 2020 Nov 1;77(11):1093-1094. doi: 10.1001/jamapsychia- try.2020.1060. 12. Brooks S. K., Webster R. K., Smith L. E. et al. The psy- chological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020. Vol. 395, Issue 10227, P. 912-920. DOI: https://doi.org/10.1016/S0140-6736(20)30460-8.
13. Pfefferbaum B, North CS. Mental Health and the Covid-19 Pandemic. N Engl J Med. 2020 Aug 6;383(6):510-512. doi: 10.1056/NEJMp2008017
14. Taquet M., Sillett R., Zhu L. Mendel J., Camplisson I., Dercon Q., Harrison P. J. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022. Vol. 9, Issue 10, P. 815-827. DOI: https://doi. org/10.1016/S2215-0366(22)00260-7.
15. Mental Health and COVID-19: Early evidence of the pan- demic’s impact. Geneva: World Health Organization: Scientific brief, 2 March 2022. https://www.who.int/publications/i/item/ WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1.
16. Charlson F, van Ommeren M, Flaxman A, Cornett J, Whiteford H, Saxena S. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta- analysis. Lancet. 2019 Jul 20;394(10194):240-248. doi: 10.1016/ S0140-6736(19)30934-1.
17. Huang, Y., Yang, C., Xu, Xf. et al. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 41, 1141–1149 (2020). https://doi.org/10.1038/s41401-020-0485-4.
18. Dosvid perezhyvannia pandemii COVID-19: dystantsiini psykholohichni doslidzhennia, dystantsiina psykholohichna pidtrymka : materialy onlain-seminariv 23 kvitnia 2020 roku «Dosvid karantynu: dystantsiina psykholohichna dopomoha i pidtrymka» ta 15 travnia 2020 roku «Dystantsiini psykholohichni doslidzhennia v umovakh pandemii Covid-19 i karantynu». Kyiv, 2020. 68 s. URI: https://ispp.org.ua/wp-content/uploads/Static/dos- vid_onl-sem_23-04-20_and_15-05-20_ncov19.pdf. (In Ukrainian).